中文 | English
Return
Total: 187 , 1/19
Show Home Prev Next End page: GO
Author:(Ding QU)

1.The intracellular pattern recognition receptors-NOD like receptors

Yanchun DING ; Peng QU

Chinese Journal of Pathophysiology 2000;0(12):-

2.Analysis of Antidepressants Used in Our Hospital During the Period 1998~2001

Falin QU ; Qinglong DING

China Pharmacy 1991;0(04):-

3.Role of nucleotide binding oligomerization domain receptor 1 as a new innate immune recognition receptor in activation of vascular smooth muscle cells

Yanchun DING ; Peng QU

Chinese Journal of Tissue Engineering Research 2007;0(11):-

4.Synergistic Effect of Nucleotide binding Oligomerization Domain 2 and Toll-like Receptor Agonists on Proliferation and Release of Proinflammatory Cytokines in Vascular Smooth Muscle Cells

Yanchun DING ; Peng QU

Chinese Journal of Hypertension 2006;0(12):-

6.TCM Data Management Based on Object Characteristics under the Background of Big Data

Changsong DING ; Haoyu QU ; Shiwen WU

Chinese Journal of Information on Traditional Chinese Medicine 2016;23(9):10-14

7.Research progress of neutrophil extracellular traps and related targeted drugs for the treatment of inflammatory diseases

Yan DING ; Jiao QU ; Yang SUN

Acta Pharmaceutica Sinica 2021;56(3):669-678

8.Chemical constituents of Galla Chinensis

Chunyuan LI ; Weijia DING ; Guirong QU

Chinese Traditional and Herbal Drugs 1994;0(08):-

9.The study on behavioral characteristics of circadian rhythm disturbance in transgenic mice of Alzheimer's disease

Xiuli CAO ; Xuesong QU ; Ruichao LIU ; Jianming DING ; Meina WU

Chinese Journal of Behavioral Medicine and Brain Science 2017;26(1):2-7

10.Diagnostic value of nuchal translucency thickness and facial profile ultrasonic markers for trisomy 21 syndrome in the first-trimester fetuses

Guangying ZHANG ; Suhui QU ; Hongyu DING ; Wei LIU ; Li WANG

Chinese Journal of Ultrasonography 2016;25(11):957-961

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 187 , 1/19 Show Home Prev Next End page: GO